Cargando…
Platelet-Derived Growth Factor Receptor Beta: A Novel Urinary Biomarker for Recurrence of Non-Muscle-Invasive Bladder Cancer
Non-muscle-invasive bladder cancer (NMIBC) is one of the most common malignant tumors in the urological system with a high risk of recurrence, and effective non-invasive biomarkers for NMIBC relapse are still needed. The human urinary proteome can reflect the status of the microenvironment of the ur...
Autores principales: | Feng, Jiayu, He, Weifeng, Song, Yajun, Wang, Ying, Simpson, Richard J., Zhang, Xiaorong, Luo, Gaoxing, Wu, Jun, Huang, Chibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011858/ https://www.ncbi.nlm.nih.gov/pubmed/24801713 http://dx.doi.org/10.1371/journal.pone.0096671 |
Ejemplares similares
-
Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
por: Tan, Wei Shen, et al.
Publicado: (2018) -
Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019) -
A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
por: Huang, Hai, et al.
Publicado: (2023) -
Improving doctor–patient communication: content validity examination of a novel urinary system-simulating physical model
por: Hu, WenGang, et al.
Publicado: (2016) -
Muscle-invasive angiosarcoma of the urinary bladder: Case report
por: Madiraju, Srigita, et al.
Publicado: (2023)